Eisai introduces Aciphex Sprinkle capsules

WOODCLIFF LAKE, N.J. — Drug maker Eisai has launched a new version of a drug used to treat gastroesophageal reflux disease, the company said Friday.

Eisai announced the availability of Aciphex Sprinkle delayed-release capsules in the 5-mg and 10-mg strengths. The Food and Drug Administration approve the drug in March.

Aciphex Sprinkle capsules, which are approved for use in children aged 1 to 11 for up to 12 weeks, are designed to be broken open and sprinkled on soft food or liquid.